Categories
Bansisons Tea Industries Ltd — Board Meeting, 02-05-2026: Board Meeting
02-05-2026 · 05:11 pm
NOVYRA PHARMACHEM released financial results for Q4 & FY26. Total revenue was ₹0.17 Cr, with a net loss of ₹5.37 Cr. EPS stood at (₹8.49). The company faces significant challenges with continuing losses.
No comments yet. Be the first to comment!